Assertio Holdings, Inc. Common Stock (ASRT) is a publicly traded Healthcare sector company. As of May 21, 2026, ASRT trades at $23.44 with a market cap of $150.70M and a P/E ratio of -3.11. ASRT moved +0.15% today. Year to date, ASRT is +143.41%; over the trailing twelve months it is +127.76%. Its 52-week range spans $7.71 to $23.46. Analyst consensus is buy with an average price target of $24.20. Rallies surfaces ASRT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Assertio and Garda Delay Tender Offer for Outstanding Shares: Assertio Therapeutics and Garda Capital Partners have mutually agreed to postpone the launch of Garda’s previously announced tender offer for all outstanding Assertio common shares. The companies did not specify a new launch date but said the delay will provide additional time to finalize documentation and regulatory processes.
| Metric | Value |
|---|---|
| Price | $23.44 |
| Market Cap | $150.70M |
| P/E Ratio | -3.11 |
| EPS | $-7.53 |
| Dividend Yield | 0.00% |
| 52-Week High | $23.46 |
| 52-Week Low | $7.71 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $102.16M |
| Net Income | $-35.69M |
| Gross Margin | 0.00% |
4 analysts cover ASRT: 0 strong buy, 2 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $24.20.